Skip to content

Contact +44 (0) 20 7060 7474 email us

Diagnostics

The Future of The in-Vitro Diagnostics Market to 2016

Increasing Diagnostic Procedures Drive Demand

Publication Date January 2010
Publisher GBI Research
Product Type Report
Pages 142
ISBN Number not applicable
Product Code GBI00021

Price

£2,310.00
approximately: $3,498 | €2,578

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

Summary

GBI Research's new report, ""The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand"" provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope:

  • Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.
  • Global Market size and company share data for seven In-Vitro Diagnostics market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.
  • Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
  • Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
  • Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.
  • Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.

Reasons to buy:

  • Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next big thing in the In-Vitro Diagnostics market landscape? - Identify, understand and capitalize
  • Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction and Overview
    • 2.1 In-Vitro-Diagnostics (IVD) Overview
  • 3 Global In-Vitro Diagnostics (IVD) Market: Market Characterization
    • 3.1 Global In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
    • 3.2 Global In-Vitro Diagnostics (IVD) Market, Revenue Forecasts ($m), 2009 - 2016
    • 3.3 Global In-Vitro Diagnostics (IVD) Market, Company Share (%), 2008
    • 3.4 Global In-Vitro Diagnostics (IVD) Market, Key Market Trends
      • 3.4.1 Entry of Diagnostic Imaging Players into the In-Vitro Diagnostics (IVD) Market Has Set Stage for New Technologies to Be Developed By Marrying the Two Disciplines
      • 3.4.2 Large Number of Private Equity/ Venture Capital (PE/VC) Investments and Collaborations in the In-Vitro Diagnostics (IVD) Sector to Fuel Innovation
      • 3.4.3 Consolidation of Laboratories across the World
    • 3.5 Global In-Vitro Diagnostics (IVD) Market: Key Technology Trends
      • 3.5.1 Emerging Technologies for Cutting Lab Costs
      • 3.5.2 New Technologies Improve Speed and Accuracy
    • 3.6 Global In-Vitro Diagnostics (IVD) Market, Market Drivers
      • 3.6.1 Economic Market Drivers
      • 3.6.2 Technological Market Drivers
      • 3.6.3 Regulatory Market Drivers
      • 3.6.4 Social Market Drivers
    • 3.7 In-Vitro Diagnostics (IVD) Market, Market Restraints
      • 3.7.1 Economic Market Restraints
      • 3.7.2 Social Market Restraints
  • 4 Global In-Vitro Diagnostics (IVD) Market: Category Analysis and Forecasts
    • 4.1 Clinical Chemistry Market: Market Characterization
      • 4.1.1 Global Clinical Chemistry Market, Revenue ($m), 2002-2009
      • 4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009-2016
      • 4.1.3 Global Clinical Chemistry Market, Company Share (%), 2008
      • 4.1.4 Clinical Chemistry Market: Market Drivers
      • 4.1.5 Clinical Chemistry Market: Market Restraints
    • 4.2 Immuno Chemistry Market: Market Characterization
      • 4.2.1 Global Immuno Chemistry Market, Revenue ($m), 2002 - 2009
      • 4.2.2 Global Immuno Chemistry Market, Revenue Forecast ($m), 2009 - 2016
      • 4.2.3 Global Immuno Chemistry Market, Company Share (%), 2008
      • 4.2.4 Immuno Chemistry Market: Market Drivers
      • 4.2.5 Immuno Chemistry Market: Market Restraints
    • 4.3 Haematology Market: Market Characterization
      • 4.3.1 Global Haematology Market, Revenues ($m), 2002 - 2009
      • 4.3.2 Global Haematology Market, Revenue Forecasts ($m), 2009 - 2016
      • 4.3.3 Global Haematology Market, Company Share (%), 2008
      • 4.3.4 Haematology Market: Market Drivers
      • 4.3.5 Haematology Market: Market Restraints
    • 4.4 Histology and Cytology Market: Market Characterization
      • 4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002 - 2009
      • 4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009 - 2016
      • 4.4.3 Global Histology and Cytology Market, Company Share (%), 2008
      • 4.4.4 Histology and Cytology Market: Market Drivers
      • 4.4.5 Histology and Cytology Market: Market Restraints
    • 4.5 Microbiology Culture Market: Market Characterization
      • 4.5.1 Global Microbiology Culture Market, Revenue ($m), 2002 - 2009
      • 4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 - 2016
      • 4.5.3 Global Microbiology Culture Market, Company Share (%), 2008
      • 4.5.4 Global Microbiology Culture Market: Market Drivers
      • 4.5.5 Microbiology Culture Market: Market Restraints
    • 4.6 Infectious Immunology Market: Market Characterization
      • 4.6.1 Global Infectious Immunology Market, Revenue ($m), 2002 - 2009
      • 4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009 - 2016
      • 4.6.3 Global Infectious Immunology Market, Company Share (%), 2008
      • 4.6.4 Global Infectious Immunology Market: Market Drivers
      • 4.6.5 Global Infectious Immunology Market: Market Restraints
    • 4.7 Genetic Testing Market: Market Characterization
      • 4.7.1 Global Genetic Testing Market, Revenue ($m), 2002 - 2009
      • 4.7.2 Global Genetic Testing Market, Revenue Forecasts ($m), 2009 - 2016
      • 4.7.3 Global Genetic Testing Market, Company Share (%), 2008
      • 4.7.4 Global Genetic Testing Market: Market Drivers
      • 4.7.5 Global Genetic Testing Market: Market Restraints
  • 5 Global In-Vitro Diagnostics (IVD) Market: Country Analysis and Forecasts
    • 5.1 Global In-Vitro Diagnostics (IVD)Market: Geographic Trends Analysis
    • 5.2 Market Characterization, North America, 2002 - 2016
      • 5.2.1 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.2.2 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.2.3 Canada In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.2.4 North America In-Vitro Diagnostics (IVD) Market, Market Drivers
      • 5.2.5 North America In-Vitro Diagnostics (IVD) Market, Market Restraints
    • 5.3 Market Characterization, Europe, 2002 - 2016
      • 5.3.1 The UK In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.3.2 The UK In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 - 2016
      • 5.3.3 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.3.4 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.3.5 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.3.6 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.3.7 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.3.8 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.3.9 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.3.10 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.3.11 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.3.12 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.3.13 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.3.14 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.3.15 Europe In-Vitro Diagnostics (IVD) Market, Market Drivers
      • 5.3.16 Europe In-Vitro Diagnostics (IVD) Market, Market Restraints
    • 5.4 Market Characterization, Asia Pacific, 2002 - 2016
      • 5.4.1 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.4.2 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.4.3 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.4.4 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.4.5 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.4.6 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.4.7 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.4.8 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.4.9 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.4.10 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.4.11 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.4.12 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.4.13 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Drivers
      • 5.4.14 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Restraints
    • 5.5 Market Characterization, South and Central America, 2002 - 2016
      • 5.5.1 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.5.2 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.5.3 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.5.4 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.5.5 Mexico In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.5.6 Mexico In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 - 2016
      • 5.5.7 South and Central America In-Vitro Diagnostics (IVD) Market, Market Drivers
      • 5.5.8 South and Central America In-Vitro Diagnostics (IVD) Market, Market Restraints
    • 5.6 Market Characterization, Middle East and Africa, 2002 - 2016
      • 5.6.1 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.6.2 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.6.3 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 - 2009
      • 5.6.4 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 - 2016
      • 5.6.5 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Drivers
      • 5.6.6 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Restraints
  • 6 Global In-Vitro Diagnostics (IVD) Market: Strategic Competitive Assessment
    • 6.1 Key Market Participants
      • 6.1.1 F. Hoffmann-La Roche Ltd
      • 6.1.2 Siemens Medical Solutions
      • 6.1.3 Abbott Laboratories
      • 6.1.4 Beckman Coulter, Inc
      • 6.1.5 bioMerieux Sa
      • 6.1.6 Ortho-Clinical Diagnostics
      • 6.1.7 Becton, Dickinson and Company
      • 6.1.8 Bio-Rad Laboratories, Inc
      • 6.1.9 Inverness Medical Innovations, Inc
  • 7 Global In-Vitro Diagnostics (IVD) Market: Product Pipeline Analysis
    • 7.1 Pipeline Products Analysis by Category
      • 7.1.1 Pipeline Products Analysis: Immuno Chemistry Market
      • 7.1.2 Pipeline Products Analysis: Infectious Immunology
    • 7.2 Key Pipeline Products Currently Undergoing Development
      • 7.2.1 Clinical Chemistry Pipeline Products
      • 7.2.2 Genetic Testing
      • 7.2.3 Haematology
      • 7.2.4 Immunochemistry
      • 7.2.5 Infectious Immunology
      • 7.2.6 Microbiology Culture
      • 7.2.7 Histology and Cytology
  • 8 Global In-Vitro Diagnostics (IVD) Market: Consolidation Landscape
    • 8.1 Deals by Type, 2006 - 2009
    • 8.2 Deals by Value and Volume, 2006 - 2009
    • 8.3 List of Deals in 2009
    • 8.4 Top 10 Acquisitions By Value, 2009
      • 8.4.1 Agilent Technologies Receives Shareholders Approval To Acquire Varian
      • 8.4.2 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS
      • 8.4.3 MDS Receives Shareholder Approval To Sell MDS Analytical Technologies To Danaher
      • 8.4.4 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S
      • 8.4.5 Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital
      • 8.4.6 Becton, Dickinson and Company Completes Acquisition Of HandyLab
      • 8.4.7 Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn
      • 8.4.8 Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences
      • 8.4.9 Gen-Probe Acquires Tepnel Life Sciences
  • 9 Appendix
    • 9.1 Definitions
      • 9.1.1 Clinical Chemistry
      • 9.1.2 Immunochemistry Test Reagents
      • 9.1.3 Haematology
      • 9.1.4 Histology And Cytology
      • 9.1.5 Microbiology Culture
      • 9.1.6 Infectious Immunology
      • 9.1.7 Genetic Testing
    • 9.2 Acronyms
    • 9.3 Methodology
      • 9.3.1 Secondary Research
      • 9.3.2 Primary Research
      • 9.3.3 Models
      • 9.3.4 Forecasts
      • 9.3.5 Expert Panels
    • 9.4 Contact Us
    • 9.5 Disclaimer
  • List of Tables
    • Table 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009
    • Table 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016
    • Table 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share ($m), 2008
    • Table 4: Clinical Chemistry Market, Global, Revenue ($m), 2002-2009
    • Table 5: Clinical Chemistry Market, Global, Revenue ($m), 2009-2016
    • Table 6: Clinical Chemistry Market, Global, Company Share ($m), 2008
    • Table 7: Immuno Chemistry Market, Global, Revenue ($m), 2002-2009
    • Table 8: Immuno Chemistry Market, Global, Revenue ($m), 2009-2016
    • Table 9: Immuno Chemistry Market, Global, Company Share ($m), 2008
    • Table 10: Haematology Market, Global, Revenues ($m), 2002-2009
    • Table 11: Haematology Market, Global, Revenue ($m), 2009-2016
    • Table 12: Haematology Market, Global, Company Share ($m), 2008
    • Table 13: Histology and Cytology Market, Global, Revenue ($m), 2002-2009
    • Table 14: Histology and Cytology Market, Global, Revenue ($m), 2009-2016
    • Table 15: Histology and Cytology Market, Global, Company Share ($m), 2008
    • Table 16: Microbiology Culture Market, Global, Revenue ($m), 2002-2009
    • Table 17: Microbiology Culture Market, Global, Revenue ($m), 2009-2016
    • Table 18: Microbiology Culture Market, Global, Company Share ($m), 2008
    • Table 19: Infectious Immunology Market, Global, Revenue ($m), 2002-2009
    • Table 20: Infectious Immunology Market, Global, Revenue ($m), 2009-2016
    • Table 21: Infectious Immunology Market, Global, Company Share ($m), 2008
    • Table 22: Genetic Testing Market, Global, Revenue ($m), 2002-2009
    • Table 23: Genetic Testing Market, Global, Revenue ($m), 2009-2016
    • Table 24: Global Genetic Testing Market, Global, Company Share ($m), 2008
    • Table 25: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009
    • Table 26: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016
    • Table 27: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009
    • Table 28: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016
    • Table 29: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009
    • Table 30: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016
    • Table 31: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009
    • Table 32: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016
    • Table 33: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009
    • Table 34: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016
    • Table 35: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009
    • Table 36: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016
    • Table 37: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009
    • Table 38: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016
    • Table 39: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009
    • Table 40: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016
    • Table 41: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009
    • Table 42: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016
    • Table 43: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009
    • Table 44: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016
    • Table 45: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009
    • Table 46: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016
    • Table 47: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
    • Table 48: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
    • Table 49: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009
    • Table 50: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016
    • Table 51: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009
    • Table 52: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016
    • Table 53: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009
    • Table 54: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016
    • Table 55: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009
    • Table 56: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016
    • Table 57: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009
    • Table 58: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016
    • Table 59: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009
    • Table 60: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016
    • Table 61: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009
    • Table 62: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016
    • Table 63: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009
    • Table 64: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016
    • Table 65: Roche's Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 66: Roche In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
    • Table 67: Siemens Medical Solutions In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
    • Table 68: Siemen's Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 69: Abbott Laboratories' Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 70: Abbott Laboratories In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
    • Table 71: Beckman Coulter's Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 72: Beckman Coulter, Inc. In-Vitro Diagnostics (IVD) Pipeline Products
    • Table 73: bioMerieux's Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 74: bioMerieux Sa, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
    • Table 75: Ortho-Clinical Diagnostics, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
    • Table 76: Becton Dickinson, Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 77: Becton, Dickinson Inc. In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
    • Table 78: Bio-Rad, Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 79: Inverness Medical Innovations, Inc., Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007-2009
    • Table 80: Inverness Medical Innovations In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
    • Table 81: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2009
    • Table 82: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009
    • Table 83: Infectious Immunology Market, Global, 2009
    • Table 84: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009
    • Table 85: Key Deals, Global In-Vitro Diagnostics (IVD) Market, 2009
  • List of Figures
    • Figure 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009
    • Figure 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016
    • Figure 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share (%), 2008
    • Figure 4: Global In-Vitro Diagnostics (IVD) Market: Key Market Trends
    • Figure 5: Global Laboratory Consolidation Landscape, 2005-2009
    • Figure 6: Global In Vitro Diagnostics Market: Key Technology Trends
    • Figure 7: Global In-Vitro Diagnostics (IVD) Market: Drivers and Restraints
    • Figure 8: List of Retail Clinics in the US and Diagnostic In-Vitro Diagnostics (IVD) Tests Offered
    • Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2002-2009
    • Figure 10: Clinical Chemistry Market, Global, Revenue ($m), 2009-2016
    • Figure 11: Clinical Chemistry Market, Global, Company Share (%), 2008
    • Figure 12: Immuno Chemistry Market, Global, Revenue ($m), 2002-2009
    • Figure 13: Immuno Chemistry Market, Global, Revenue ($m), 2009-2016
    • Figure 14: Immuno Chemistry Market, Global, Company Share (%),2008
    • Figure 15: Haematology Market, Global, Revenue ($m), 2002-2009
    • Figure 16: Haematology Market, Global, Revenue ($m), 2009-2016
    • Figure 17: Haematology Market, Global, Company Share (%), 2008
    • Figure 18: Histology and Cytology Market, Global, Revenue ($m), 2002-2009
    • Figure 19: Histology and Cytology Market, Global, Revenue ($m), 2009-2016
    • Figure 20: Histology and Cytology Market, Global, Company Share (%), 2008
    • Figure 21: Microbiology Culture Market, Global, Revenue ($m), 2002-2009
    • Figure 22: Microbiology Culture Market, Global, Revenue ($m), 2009-2016
    • Figure 23: Microbiology Market, Global, Company Share (%),2008
    • Figure 24: Infectious Immunology Market, Global, Revenue ($m), 2002-2009
    • Figure 25: Infectious Immunology Market, Global, Revenue ($m), 2009-2016
    • Figure 26: Infectious Immunology Market, Global, Company Share (%), 2008
    • Figure 27: Genetic Testing Market, Global, Revenue ($m), 2002-2009
    • Figure 28: Genetic Testing Market, Global, Revenue ($m), 2009-2016
    • Figure 29: Global Genetic Testing Market, Global, Company Share (%),2008
    • Figure 30: In-Vitro Diagnostics (IVD) Market, Global, Geographic Trends Analysis
    • Figure 31: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009
    • Figure 32: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016
    • Figure 33: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009
    • Figure 34: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016
    • Figure 35: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009
    • Figure 36: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016
    • Figure 37: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009
    • Figure 38: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016
    • Figure 39: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009
    • Figure 40: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016
    • Figure 41: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009
    • Figure 42: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016
    • Figure 43: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009
    • Figure 44: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016
    • Figure 45: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009
    • Figure 46: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016
    • Figure 47: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009
    • Figure 48: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016
    • Figure 49: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009
    • Figure 50: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016
    • Figure 51: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009
    • Figure 52: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016
    • Figure 53: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
    • Figure 54: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
    • Figure 55: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009
    • Figure 56: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016
    • Figure 57: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009
    • Figure 58: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016
    • Figure 59: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009
    • Figure 60: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016
    • Figure 61: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009
    • Figure 62: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016
    • Figure 63: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009
    • Figure 64: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016
    • Figure 65: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009
    • Figure 66: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016
    • Figure 67: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009
    • Figure 68: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016
    • Figure 69: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009
    • Figure 70: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016
    • Figure 71: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products Analysis by Category, 2009
    • Figure 72: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009
    • Figure 73: Infectious Immunology Market, Global, 2009
    • Figure 74: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009
    • Figure 75: Deals By Value and Volume, Global In-Vitro Diagnostics (IVD) Market, Value ($m), 2006-2009
    • Figure 76: GBI Research Methodology